RELIANCE INDUSTRIES Stock tips
Reliance Life Sciences, the biopharmaceutical unit of Reliance IndustriesBSE 0.26 %, has acquired the global rights for biosimilars, or copies, of Infliximab from Boston based Epirus Biopharmaceuticals. Infliximab is used to treat a broad range of medical conditions like rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis
Nice Article...
ReplyDeleteHow do I trade on the stock market?
Raymond Share Value
Media Shares Assorted